Publications by authors named "Duncan Armour"

Claim this Profile
O
Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIV.
David A Price, Duncan Armour, Marcel de Groot, Derek Leishman, Carolyn Napier

Curr Top Med Chem· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc.
David A Price, Duncan Armour, Marcel de Groot, Derek Leishman, Carolyn Napier

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of CCR5 receptor antagonists for the treatment of HIV infection: hit-to-lead studies.
Duncan Armour, Marcel J de Groot, Martin Edwards, Manos Perros, David A Price

ChemMedChem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of tropane-derived CCR5 receptor antagonists.
Duncan R Armour, Marcel J de Groot, David A Price, Blanda L C Stammen, Anthony Wood

Chem Biol Drug Des· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS.
Anthony Wood, Duncan Armour

Prog Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.
Patrick Dorr, Mike Westby, Susan Dobbs, Paul Griffin, Becky Irvine, Duncan Armour

Antimicrob Agents Chemother· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis